DE3585713D1 - Immunoverstaerker und verfahren zu ihrer herstellung. - Google Patents

Immunoverstaerker und verfahren zu ihrer herstellung.

Info

Publication number
DE3585713D1
DE3585713D1 DE8585110104T DE3585713T DE3585713D1 DE 3585713 D1 DE3585713 D1 DE 3585713D1 DE 8585110104 T DE8585110104 T DE 8585110104T DE 3585713 T DE3585713 T DE 3585713T DE 3585713 D1 DE3585713 D1 DE 3585713D1
Authority
DE
Germany
Prior art keywords
immuno
amplifier
production
materials
nonspecifically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585110104T
Other languages
English (en)
Inventor
Arthur A Gottlieb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3585713D1 publication Critical patent/DE3585713D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Processing Of Solid Wastes (AREA)
DE8585110104T 1984-08-24 1985-08-12 Immunoverstaerker und verfahren zu ihrer herstellung. Expired - Lifetime DE3585713D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/643,724 US4616079A (en) 1984-08-24 1984-08-24 Immunoamplifiers and processes for the extraction thereof

Publications (1)

Publication Number Publication Date
DE3585713D1 true DE3585713D1 (de) 1992-04-30

Family

ID=24582025

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585110104T Expired - Lifetime DE3585713D1 (de) 1984-08-24 1985-08-12 Immunoverstaerker und verfahren zu ihrer herstellung.

Country Status (4)

Country Link
US (1) US4616079A (de)
EP (1) EP0173889B1 (de)
AT (1) ATE74007T1 (de)
DE (1) DE3585713D1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1286989C (en) 1985-12-26 1991-07-30 A. Arthur Gottlieb Immunoamplifiers and related compositions
US4699898A (en) * 1985-12-26 1987-10-13 Imreg, Inc. Tripeptides affecting immune response
EP0238851B1 (de) * 1986-02-19 1992-12-09 Imreg, Inc. Verfahren und Mittel zum Prüfen eines Immunsystems
US4710380A (en) * 1986-04-04 1987-12-01 Imreg, Inc. Treatment of autoimmune disorders with immunoamplifiers
EP0247538A3 (de) * 1986-05-28 1989-08-30 Imreg, Inc. Immunosuppressivum und Verfahren zu seiner Extraktion
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
US5013546A (en) * 1988-08-23 1991-05-07 Imreg, Inc. Methods for modulating antibody production in treating patients with AIDS, ARC and other diseases
WO1992000087A1 (en) * 1990-07-02 1992-01-09 National Jewish Center For Immunology And Respiratory Medicine Process for obtaining pure peptide transfer factor, transfer factor thus obtained and uses thereof
EP0537280B1 (de) * 1990-07-02 1997-09-17 National Jewish Center For Immunology And Respiratory Medicine Herstellung und verwendung von transfer-faktor
US5883224A (en) * 1996-04-19 1999-03-16 Cytokine Sciences, Inc. Characterization of transfer factors and methods of use
US7632818B2 (en) * 2003-03-20 2009-12-15 Gottlieb Marise S Method for treating conditions associated with the Metabolic Syndrome (Syndrome X)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
FI78483C (fi) * 1980-05-14 1989-08-10 A Arthur Gottlieb Rening av modulatorer foer immunsystem.
US4435384A (en) * 1982-04-30 1984-03-06 Viragen, Inc. Transfer factor composition and skin treatment
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system

Also Published As

Publication number Publication date
US4616079A (en) 1986-10-07
EP0173889B1 (de) 1992-03-25
EP0173889A2 (de) 1986-03-12
ATE74007T1 (de) 1992-04-15
EP0173889A3 (en) 1987-02-04

Similar Documents

Publication Publication Date Title
AT305288B (de) Verfahren zur Herstellung neuer 1-substituierter Tetrahydro-2-(1H)pyrimidone
DE3585713D1 (de) Immunoverstaerker und verfahren zu ihrer herstellung.
ZA811084B (en) Process for isolating rosmarinic acid from plants
ATE54415T1 (de) Verfahren zur herstellung eines impfstoffs einer herpes-simplex-virusuntereinheit.
DK232483D0 (da) Fremgangsmade til fremstilling af ws 6049-forbindelser
DK160274C (da) Fremgangsmaade til fremstilling af 4'-deoxydaunorubicin eller 4'-deoxydoxorubicin
BG40482A3 (en) Method for preparing phenetanolamines
NL7903400A (nl) Werkwijze voor de bereiding van alpha,beta-onverzadigde n-gesubstitueerde carbonzuuramiden.
BG38163A3 (en) Method for preparing pyrimidones
DK617386D0 (da) Fremgangsmaade til fremstilling af 2-keto-d-glucarsyre
IT7820240A0 (it) Supporti per immobulizzare e stabilizzare enzimi e procedimento per la sua preparazione.
BG40803A3 (en) Method for preparing arylcyclobutylalkylaminic derivatives
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
BG35749A3 (en) Method for preparing 20- dihydro- 20, 23- dideoxytilonolide
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
IT8223453A0 (it) Procedimento per intensificare le trasformazioni microbiologiche di steroidi usando additivi costituiti da ciclodestrine.
DK4586A (da) Fremgangsmaade til formering af begoniearter
BG38939A3 (en) Method for preparing 1, 1- dioxopenicillanoyloxymethyl ester of 6- (2- amino- 2- phenylacetamido)- penicillanic acid
DE2962198D1 (en) Process for the preparation of thermostable n-alkyl-arylsulphonamides and their use as plasticizers for polyamides
JPS51125787A (en) Method for cultivating and processing of mashrooms
BG39977A3 (en) Method for preparing derivatives of furyloxazolylacetic acid
ES8301956A1 (es) "procedimiento de aislar acido (+)-usnico".
ES8404187A1 (es) Procedimiento para aislar antigeno carcinoembrional a partir de extractos con acido perclorico que contienen al mismo
BG47345A3 (en) Method for preparing of dialkyloxalacetates

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted